Contribution: Industrial Research Assistance Program
Puzzle Medical Devices Inc.
$250,500.00
Increasing durability of a left ventricular assist device
FY 2025-26 · 2025-06-01
Summary
The firm is developing a heart pump for patients with heart failure. The objective is to increase its durability to support longer term patients.
Department
Program
Industrial Research Assistance Program
Recipient
Location
Montreal|Montréal, Quebec, Canada
Recipient Type
For-profit organization
Business Number
752064089
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2025-06-01 | 2025-26 | $250,500.00 |
| 1 | 2025-06-01 | 2025-26 | $250,500.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by -28 days.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de -28 jours.
Agreement End Date
2026-07-31
Agreement Number
1033856
Agreement Start Date
2025-06-01
Agreement Title
Increasing durability of a left ventricular assist device
Agreement Title (French)
Augmenter la durabilité d’un dispositif d’assistance ventriculaire gauche
Agreement Type
Contribution
Agreement Value
$250,500.00
Amendment Date
2026-03-09
Amendment Number
1
Coverage
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity. | Les projets du Programme d'aide à la recherche industrielle favorisent la création de richesse au Canada grâce à l'innovation technologique et renforcent l'écosystème canadien de l'innovation en créant de nouvelles capacités industrielles.
Description
The firm is developing a heart pump for patients with heart failure. The objective is to increase its durability to support longer term patients.
Description (French)
L’entreprise développe une pompe cardiaque pour les patients souffrant d’insuffisance cardiaque. L’objectif est d’augmenter sa durabilité afin de prendre en charge les patients à plus long terme.
Expected Results
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Expected Results (French)
Les résultats attendus du Programme d’aide à la recherche industrielle du CNRC sont axés sur la croissance des petites et moyennes entreprises (PME) grâce à l’innovation et à la création de richesse pour le Canada.
Federal Riding
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding (French)
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number
24077
NAICS Code
33911
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program
Program Name (French)
Programme d’aide à la recherche industrielle
Program Purpose
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Program Purpose (French)
Les contributions versées aux entreprises en vertu du Programme d’aide à la recherche industrielle ont pour objectif d’apporter un soutien aux petites et moyennes entreprises (PME) afin qu’elles puissent approfondir leurs connaissances en matière d’innovation et renforcer leur capacité d’innovation, de croissance et de création de richesse pour le Canada.
Recipient Business Number
752064089
Recipient City
Montreal|Montréal
Recipient Country
CA
Recipient Legal Name
Puzzle Medical Devices Inc.
Recipient Postal Code
H4C 2Z6
Recipient Province or Territory
QC
Recipient Type
F
Reference Number
172-2025-2026-Q2-1033856
